Meta-prebiotics: a new way to control the intestinal microbiota
- Authors: Кrylova I.А.1, Kupaev V.I.1, Lyamin А.V.1, Ismatullin D.D.1
-
Affiliations:
- Samara State Medical University
- Issue: Vol 6, No 1 (2021)
- Pages: 29-32
- Section: Gastroenterology
- URL: https://journals.rcsi.science/2500-1388/article/view/64217
- DOI: https://doi.org/10.35693/2500-1388-2021-6-1-29-32
- ID: 64217
Cite item
Full Text
Abstract
Objectives – to analyze the quality and quantity of the intestinal microflora of relatively healthy people and/or of those who did not visit a doctor in the last 3 months, before and 1 month after taking a meta-prebiotic complex containing dietary fiber (inulin) and oligosaccharides (oligofructose).
Material and methods. We examined the individuals who considered themselves healthy and/or did not consult a doctor during the past 3 months. To detect the presence of dyspeptic complaints, the clinical data were collected. 114 people with different suboptimal status and non-specific dyspeptic complaints were chosen for the study and underwent the clinical examination for the degree of gut microbiota imbalance before taking the meta-prebiotic complex. 78 people followed the course of the meta-prebiotic and were examined after 1 month after the start.
Results. We have obtained new data on intestinal biocenosis at various suboptimal status in relatively healthy people: the total number of bacteria is insufficient. When using a meta-prebiotic complex containing inulin and oligofructose, the composition of the intestinal microflora was improved due to the decreased cases of detection of opportunistic enterobacteria and other gram-negative microorganisms.
Conclusion. The significance of studying the intestinal microbiotic complex in patients with the increased suboptimal health status is proved, and the earlier active screening of this category of patients is recommended.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Irina А. Кrylova
Samara State Medical University
Author for correspondence.
Email: raznoe.2009@list.ru
ORCID iD: 0000-0003-1757-0774
PhD, Associate professor, Department of Family medicine
Russian Federation, SamaraVitalii I. Kupaev
Samara State Medical University
Email: vk1964sam@rambler.ru
ORCID iD: 0000-0003-2639-0003
д.м.н., профессор, заведующий кафедрой семейной медицины ИПО
Russian Federation, SamaraАrtem V. Lyamin
Samara State Medical University
Email: avlyamin@rambler.ru
ORCID iD: 0000-0002-5905-1895
PhD, Associate professor, Department of General and clinical microbiology, immunology and allergology, bacteriologist of the microbiological department, Clinics of SamSMU
Russian Federation, SamaraDanir D. Ismatullin
Samara State Medical University
Email: danirhalitov@mail.ru
ORCID iD: 0000-0002-4283-907X
bacteriologist of the microbiological department, Clinics of SamSMU, assistant of the Department of General and clinical microbiology, immunology and allergology
Russian Federation, SamaraReferences
- Bruno G, Zaccari P, Rocco G, Scalese G, Panetta Cr, Porowska B, Pontone S, Severi C. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World J Gastroenterol. 2019;25(22):2706-2719. doi: 10.3748/wjg.v25.i22.2706 PMID: 31235994
- Wei Wang, Yu-Xiang Yan. Suboptimal Health: a new health dimension for translational medicine. Clinical and translational medicine. 2012;1(28):2-6. doi: 10.1186/2001-1326-1-28 PMID: 23369267
- Simerzin VV, Fatenkov OV, Gagloeva IV, et al. Innovations in the diagnosis and treatment of patients with hypertriglyceridemia. Science and innovation in medicine. 2017;1(5):43-51. (In Russ.). [Симерзин В.В., Фатенков О.В., Гаглоева И.В. и др. Инновации в диагностике и лечении пациентов с гипертриглицеридемиями. Наука и инновации в медицине. 2017;1(5):43-51]. doi: 10.35693/2500-1388-2017-2-1-43-51
- Global Health Estimates 2015: Deaths by cause, age, sex, by country and by region, 2000-2015. Geneva: World Health Organization; 2016.
- Zmora N, Zilberman-Schapira G, Suez J, et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell. 2018;6(174):1388-1405. doi: 10.1016/j.cell.2018.08.041 PMID: 30193112
- Suez J, Zmora N, Zilberman-Schapira G, et al. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell. 2018;6(174):1406-1423. doi: 10.1016/j.cell.2018.08.047 PMID: 30193113
- Darmov IV, Chicherin IYu, Pogorelsky IP, et al. Survival of probiotic microorganisms in the gastrointestinal tract of experimental animals. J Infectology. 2012;1(4):68-74. (In Russ.). [Дармов И.В., Чичерин И.Ю., Погорельский И.П. и др. Выживаемость микроорганизмов пробиотиков в желудочно-кишечном тракте экспериментальных животных. Журнал инфектологии. 2012;1(4):68-74]. doi: 10.22625/2072-6732-2012-4-1-68-74
- Chicherin IYu, Pogorelsky IP, Lundovskikh IG, et al. Comparative assessment of survival of probiotic microorganisms during transit through the gastrointestinal tract of experimental animals and human volunteers. Infectious diseases. 2016;3(14):37-48. (In Russ.). [Чичерин И.Ю., Погорельский И.П., Лундовских И.Г. и др. Сравнительная оценка выживаемости и приживаемости пробиотических микроорганизмов при транзите по ЖКТ экспериментальных животных и людей-добровольцев. Инфекционные болезни. 2016;3(14):37-48].
- Abbasi J. Are Probiotics Money Down the Toilet? Or Worse? JAMA. 2019;321(7):633-635. doi: 10.1001/jama.2018.20798. PMID: 30698619
- Fominyh YuA, Zaharenko SM, Balukova EV. Infectious agents – intestinal microflora –infringement of the motility of intestines – the metabolic syndrome: cause and effect mutual relations. Preventive and clinical medicine. 2011;3(40):317-321. (In Russ.). [Фоминых Ю.А., Захаренко С.М., Балукова Е.В. Инфекционные агенты – кишечная микрофлора – нарушение моторики кишечника – метаболический синдром: причинно-следственные взаимоотношения. Профилактическая и клиническая медицина. 2011;3(40):317-321].
Supplementary files
